The market size for collagen hydrolysates surpassed USD 1.1 billion in 2022 and is projected to exhibit a Compound Annual Growth Rate (CAGR) exceeding 7.5% from 2022 to 2032. The North American collagen hydrolysates market is anticipated to record a CAGR of 7.2% between 2022 and 2032. By 2027, the hydrolyzed collagen market is forecasted …
Author Archives: Editor AM
Over-the-Counter Pain Medication Market Aims for a US$ 27.7 Billion Valuation by 2028-FMI Projection
A recent report by Future Market Insights (FMI) projects that the over-the-counter pain medication market sales sector will reach US$ 21.8 billion in 2022. This market is predicted to increase in response to shifting attitudes on prescription generic drugs. According to the estimate, market sales will reach US$ 27.7 billion by 2028, growing at a quicker 4.1% …
Seasonal Affective Disorder Therapeutics Market Poised for Growth, Anticipating US$ 1.1 Billion by 2028-FMI Projection
According to the study, medications known as selective serotonin reuptake inhibitors, or SSRIs, are frequently used to treat seasonal affective disorder. There are several branded and generic medications available on the seasonal affective disorder therapeutics market size however, buproban and citalopram continue to sell at a relatively higher rate. FMI credits this dominance to the widely accessible …
Dental Lasers Market Set to Shine Bright, Projected to Illuminate at US$ 737.4 Million by 2033-FMI Projection
It is anticipated that the dental lasers market will be worth US$ 737.4 million by 2033 and US$ 492.2 million by 2023. Dental laser sales are anticipated to increase during the course of the anticipated year at a notable CAGR of 4.1%. The recent advancements in laser technology have also contributed to the steady growth …
Cytomegalovirus Treatment Market Surges to a Remarkable US$ 326 Million by 2028-FMI Projection
In 2022, the global cytomegalovirus treatment market is expected to be worth US$ 228.8 million. Demand for cytomegalovirus treatment is expected to reach US$ 326 Million by the end of 2028, growing at a CAGR of 6.1% (2022 to 2028). The industry that treats cytomegaloviruses (CMVs) is leading the charge in combating a powerful viral …
Chemotherapy-Induced Treatment Market Envisions a Steady 3.2% CAGR Journey Through 2028-FMI Projection
With a 3.3% cumulative annual growth rate (CAGR), the chemotherapy-induced myelosuppression treatments market is predicted to rise from its current size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028. A new study by FMI reveals that the chemotherapy-induced myelosuppression treatment market is expected to grow at a subdued 3% y-o-y in …
Antibiotic Susceptibility Testing Market Sets Sights on US$ 4.05 Billion Revenue by 2028-FMI Projection
In 2021, the antibiotic susceptibility testing market generated US$ 2.82 billion in revenue. By 2028, the global market is projected to have grown at a compound annual growth rate of 5.2% and be valued US$ 4.05 billion. •Infectious diseases, prevailing at a high pace •Increasing rate and tenure of hospitalization •Growing significance of early diagnostics •Soaring …
Laboratory Balances and Scales Market Surges Beyond US$ 2.0 Billion by 2033-FMI Projection
Between 2023 and 2033, the laboratory balances and scales market is projected to grow at a 4.3% average CAGR. The market is anticipated to grow from its predicted value of US$ 1.31 billion in 2023 to a market share of US$ 2.0 billion by 2033. •The market expansion is fueled by the increased use of …
Prothrombin Complex Concentrates Market Sets Sail on a US$ 1.2 Billion Odyssey by 2033-FMI Projection
From a predicted US$ 772.0 million in 2023, the prothrombin complex concentrates market sales is expected to reach a valuation of US$ 1.2 billion by 2033. Demand for prothrombin complex concentrate is expected to rise at a steady 4.1% CAGR, with China, India, the US, and the UK emerging as key producers. The global Prothrombin …
Frontotemporal Disorders Treatment Market Charting Course for a Remarkable US$ 451.4 Million by 2028-FMI Projection
The frontotemporal disorders therapy market sales is anticipated to reach a valuation of US$ 451.4 million by the end of 2028, based on the company’s most recent study. With an average annual growth rate of 4.7% through 2028, the frontotemporal disorders therapeutic market research indicates enormous expansion potential. The increasing funding by the governments across …